[go: up one dir, main page]

FI963452L - Förfarande för framställning av epoxid - Google Patents

Förfarande för framställning av epoxid Download PDF

Info

Publication number
FI963452L
FI963452L FI963452A FI963452A FI963452L FI 963452 L FI963452 L FI 963452L FI 963452 A FI963452 A FI 963452A FI 963452 A FI963452 A FI 963452A FI 963452 L FI963452 L FI 963452L
Authority
FI
Finland
Prior art keywords
preparing epoxide
epoxide
preparing
Prior art date
Application number
FI963452A
Other languages
English (en)
Finnish (fi)
Other versions
FI120259B (sv
FI963452A0 (sv
Inventor
David Askin
Kan K Eng
Peter E Maligres
Paul J Reider
Kai Rossen
Ralph P Volante
Veena Upadhyay
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22764868&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI963452(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI963452A0 publication Critical patent/FI963452A0/sv
Publication of FI963452L publication Critical patent/FI963452L/sv
Application granted granted Critical
Publication of FI120259B publication Critical patent/FI120259B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI963452A 1994-03-04 1996-09-03 Förfarande för framställning av epoxid FI120259B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20607494A 1994-03-04 1994-03-04
US20607494 1994-03-04
US9502347 1995-02-27
PCT/US1995/002347 WO1995023797A1 (en) 1994-03-04 1995-02-27 Process for making an epoxide

Publications (3)

Publication Number Publication Date
FI963452A0 FI963452A0 (sv) 1996-09-03
FI963452L true FI963452L (sv) 1996-09-03
FI120259B FI120259B (sv) 2009-08-31

Family

ID=22764868

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963452A FI120259B (sv) 1994-03-04 1996-09-03 Förfarande för framställning av epoxid

Country Status (25)

Country Link
EP (1) EP0748319B1 (sv)
JP (1) JP3871705B2 (sv)
KR (1) KR100387741B1 (sv)
CN (1) CN1066728C (sv)
AT (1) ATE210662T1 (sv)
AU (1) AU690231B2 (sv)
BR (1) BR9506977A (sv)
CA (1) CA2183976C (sv)
CZ (1) CZ291816B6 (sv)
DE (1) DE69524578T2 (sv)
DK (1) DK0748319T3 (sv)
ES (1) ES2167419T3 (sv)
FI (1) FI120259B (sv)
HR (1) HRP950096B1 (sv)
HU (1) HU222750B1 (sv)
MX (1) MX9603871A (sv)
NZ (1) NZ281866A (sv)
PT (1) PT748319E (sv)
RO (1) RO117696B1 (sv)
RU (1) RU2137769C1 (sv)
SK (1) SK283067B6 (sv)
TW (1) TW380137B (sv)
UA (1) UA45968C2 (sv)
WO (1) WO1995023797A1 (sv)
YU (1) YU49010B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728840A (en) * 1994-03-04 1998-03-17 Merck & Co., Inc. Process for making an epoxide
TW415948B (en) * 1995-10-30 2000-12-21 Merck & Co Inc Process for synthesizing epoxide and halohydrin
US5981759A (en) * 1997-06-20 1999-11-09 Merck & Co., Inc. Process for indinavir intermediate
SI2623113T1 (sl) 2005-11-09 2017-08-31 Onyx Therapeutics, Inc. Spojina za inhibicijo encimov
NZ597545A (en) 2006-06-19 2013-07-26 Proteolix Inc Peptide epoxyketones for proteasome inhibition
PL2207791T5 (pl) 2007-10-04 2020-07-27 Onyx Therapeutics, Inc. Krystaliczne peptydo- epoksy ketonowe inhibitory proteazy i synteza keto-epoksydów Aminokwasowych
KR20110073584A (ko) 2008-10-21 2011-06-29 오닉스 세라퓨틱스, 인크. 펩티드 에폭시케톤과의 병용 요법
TWI504598B (zh) 2009-03-20 2015-10-21 Onyx Therapeutics Inc 結晶性三肽環氧酮蛋白酶抑制劑
EP2498793B1 (en) 2009-11-13 2019-07-10 Onyx Therapeutics, Inc. Oprozomib for use in metastasis suppression
EP2542238B1 (en) 2010-03-01 2015-08-12 Onyx Therapeutics, Inc. Compounds for immunoproteasome inhibition
BR112012027901A2 (pt) * 2010-04-30 2015-09-08 Univ Indiana Res & Tech Corp processos para preparar linezolida
US9309283B2 (en) 2012-07-09 2016-04-12 Onyx Therapeutics, Inc. Prodrugs of peptide epoxy ketone protease inhibitors
CN104692987B (zh) * 2015-01-22 2017-05-17 北京大学 卤代醇及其衍生物的廉价高效合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072237A1 (en) * 1991-07-02 1993-01-03 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral –-amino epoxides
CA2081970C (en) * 1991-11-08 1997-07-08 Joseph P. Vacca Hiv protease inhibitors useful for the treatment of aids

Also Published As

Publication number Publication date
BR9506977A (pt) 1997-09-02
DE69524578D1 (de) 2002-01-24
CA2183976A1 (en) 1995-09-08
PT748319E (pt) 2002-05-31
KR970701714A (ko) 1997-04-12
RU2137769C1 (ru) 1999-09-20
AU690231B2 (en) 1998-04-23
HRP950096A2 (en) 1997-06-30
FI120259B (sv) 2009-08-31
CZ291816B6 (cs) 2003-06-18
DE69524578T2 (de) 2002-07-18
KR100387741B1 (ko) 2003-10-04
SK112296A3 (en) 1997-02-05
NZ281866A (en) 1998-05-27
CN1146768A (zh) 1997-04-02
CA2183976C (en) 2005-02-01
HRP950096B1 (en) 2002-06-30
TW380137B (en) 2000-01-21
EP0748319B1 (en) 2001-12-12
YU14595A (sh) 1997-12-05
JPH09509929A (ja) 1997-10-07
YU49010B (sh) 2003-04-30
MX9603871A (es) 1997-07-31
CN1066728C (zh) 2001-06-06
ATE210662T1 (de) 2001-12-15
JP3871705B2 (ja) 2007-01-24
HUT75611A (en) 1997-05-28
SK283067B6 (sk) 2003-02-04
CZ254396A3 (en) 1997-01-15
ES2167419T3 (es) 2002-05-16
EP0748319A1 (en) 1996-12-18
FI963452A0 (sv) 1996-09-03
UA45968C2 (uk) 2002-05-15
HU222750B1 (hu) 2003-09-29
RO117696B1 (ro) 2002-06-28
AU1882895A (en) 1995-09-18
DK0748319T3 (da) 2002-03-18
HU9602412D0 (en) 1996-11-28
WO1995023797A1 (en) 1995-09-08

Similar Documents

Publication Publication Date Title
FI962069L (sv) Förfarande för framställning av karpolaktam
FI991477L (sv) Förfarande för framställning av tolterodin
FI945856A0 (sv) Förfarande för framställning av level-off-DP-cellulosa
FI954498L (sv) Förfarande för framställning av persaltpartiklar
FI951780L (sv) Förfarande för framställning av katalytkomponenter
FI970102L (sv) Förfarande för syntetisering av substituerade sulfoxider
FI961071A0 (sv) Förfarande för framställning av zeolit
DE69513336D1 (de) Positioniermaschine
FI943196L (sv) Mottagningsförfarande och mottagare
FI952959L (sv) Förfarande för framställning av cellulosalösningar
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
NO20004738D0 (no) FremgangsmÕte for fremstilling av et epoksyd
FI951903L (sv) Förfarande för framställning av ginkgolid B ur ginkolid C
NO20004739D0 (no) FremgangsmÕte for fremstilling av et oksiran
FI952585L (sv) Förfarande för framställning av bensopyranföreningar
FI963344L (sv) Förfarande för framställning av substituerade tiazoler
FI955800L (sv) Metod att framställa aminoalkylguanidiner
FI963452L (sv) Förfarande för framställning av epoxid
FI972720A0 (sv) Förfarande för framställning av lamotrigin
FI950346L (sv) Förfarande för framställning av tioeterkonjugat
FI931850L (sv) Foerfarande foer framstaellning av en mellanprodukt
FI952484L (sv) Förfarande för framställning av metallhydroxider
EE9800240A (et) Meetod fermenteeritava virde valmistamiseks
FI964001L (sv) Förfarande för framställning av 7-trialkylsilylbackatin III
FI953673L (sv) Förfarande för framställning av tioamider

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120259

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

Free format text: MERCK SHARP & DOHME CORP.

MM Patent lapsed